Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) shot up 6% on Friday . The company traded as high as $35.53 and last traded at $35.21. 14,465 shares traded hands during trading, a decline of 100% from the average session volume of 6,406,522 shares. The stock had previously closed at $33.21.
A number of equities analysts have commented on TDOC shares. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Teladoc Health from $78.00 to $44.00 in a report on Thursday, April 28th. William Blair cut shares of Teladoc Health from an “outperform” rating to a “market perform” rating in a research report on Thursday, April 28th. Robert W. Baird cut their price target on shares of Teladoc Health from $72.00 to $64.00 in a report on Wednesday, April 27th. Guggenheim downgraded Teladoc Health from a “buy” rating to a “neutral” rating in a research report on Thursday, April 28th. Finally, Credit Suisse Group cut Teladoc Health from an “outperform” rating to a “neutral” rating and lowered their price objective for the stock from $114.00 to $35.00 in a research report on Thursday, April 28th. One investment analyst has rated the stock with a sell rating, eighteen have given a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $87.00.
The stock has a market cap of $5.60 billion, a PE ratio of -0.82 and a beta of 0.81. The business has a 50 day moving average price of $35.25 and a 200 day moving average price of $60.79. The company has a quick ratio of 3.71, a current ratio of 3.94 and a debt-to-equity ratio of 0.17.
In other Teladoc Health news, CFO Mala Murthy sold 4,053 shares of the stock in a transaction on Monday, June 27th. The shares were sold at an average price of $37.32, for a total transaction of $151,257.96. Following the transaction, the chief financial officer now directly owns 27,295 shares of the company’s stock, valued at $1,018,649.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Daniel Trencher sold 1,000 shares of the business’s stock in a transaction dated Friday, June 17th. The stock was sold at an average price of $29.12, for a total transaction of $29,120.00. Following the sale, the senior vice president now directly owns 28,408 shares of the company’s stock, valued at approximately $827,240.96. The disclosure for this sale can be found here. Corporate insiders own 1.55% of the company’s stock.
A number of large investors have recently bought and sold shares of the business. Future Financial Wealth Managment LLC acquired a new stake in shares of Teladoc Health in the fourth quarter valued at about $29,000. CarsonAllaria Wealth Management Ltd. acquired a new stake in Teladoc Health in the 4th quarter valued at about $30,000. DB Wealth Management Group LLC purchased a new position in Teladoc Health in the 1st quarter worth approximately $25,000. McCarthy Asset Management Inc. purchased a new position in Teladoc Health in the 1st quarter worth approximately $25,000. Finally, Oliver Lagore Vanvalin Investment Group acquired a new position in shares of Teladoc Health during the 1st quarter worth approximately $27,000. Institutional investors own 87.17% of the company’s stock.
About Teladoc Health (NYSE:TDOC)
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- Accolade Moves Higher But Growth Is Slowing
- ZIM Integrated Shipping Services (ZIM): Don’t Miss This Dividend
- RH Gives Good Reason To Get Defensive
- Why Rio Tinto Group (RIO) Is An Undervalued Opportunity
- Guidewire Software Stock is Set to Rebound
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.